The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20191406: Thoma Bravo Discover Fund II Global L.P.; Wells Fargo & Company
20191409: FirstService Corporation; Delos Investment Fund, L.P.
20191410: JPMorgan Chase & Co.; InstaMed Holdings, Inc.
20191413: Informa plc; IHS Markit Ltd.
20191416: Vista Equity Partners Fund VII-A, L.P.; Trident VI, L.P.
20191426: Wells Fargo & Company; Mark S. Moussa
20191440: Evolent Health, Inc.; University Health Care, Inc.
1906004 Informal Interpretation
20191323: Benjamin Horowitz; Okta, Inc
20191396: Eagle Parent Holdings, LLC; Amber Road, Inc.
Cure Encapsulations, Inc.
The FTC today announced its first case challenging a marketer’s use of fake paid reviews on an independent retail website. In settling the agency’s complaint, Cure Encapsulations, Inc. and its owner, Naftula Jacobowitz, resolved allegations that they made false and unsubstantiated claims for their garcinia cambogia weight-loss supplement and that they paid a third-party website to write and post fake reviews on Amazon.com.